Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
163.4 USD | +0.75% |
|
-1.09% | -18.38% |
14/06 | Morgan Stanley Adjusts Price Target on NICE to $240 From $290, Maintains Overweight Rating | MT |
12/06 | RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating | MT |
Sales 2024 * | 2.72B 227B | Sales 2025 * | 3.05B 255B | Capitalization | 10.37B 866B |
---|---|---|---|---|---|
Net income 2024 * | 449M 37.5B | Net income 2025 * | 543M 45.36B | EV / Sales 2024 * | 3.27 x |
Net cash position 2024 * | 1.47B 123B | Net cash position 2025 * | 2.28B 191B | EV / Sales 2025 * | 2.66 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
18.3
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.2% |
Latest transcript on NICE Ltd.
1 day | +0.78% | ||
1 week | -1.09% | ||
Current month | -11.29% | ||
1 month | -14.89% | ||
3 months | -37.74% | ||
6 months | -19.58% | ||
Current year | -18.38% |
![Extreme 160.74](/images/extremecours_fleche.png)
![Extreme 155.23](/images/extremecours_fleche.png)
![Extreme 155.23](/images/extremecours_fleche.png)
![Extreme 149.54](/images/extremecours_fleche.png)
![Extreme 149.54](/images/extremecours_fleche.png)
![Extreme 110.59](/images/extremecours_fleche.png)
![Extreme 37.84](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30/14/30 |
Darren Rushworth
PSD | President | 56 | 01/17/01 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01/13/01 |
David Kostman
CHM | Chairman | 59 | 01/01/01 |
Dan Falk
BRD | Director/Board Member | 79 | 01/01/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.31% | 16 M€ | +2.01% | ||
0.60% | 2 M€ | +24.97% | ||
0.28% | 7 M€ | -.--% | - | |
0.16% | 20 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 162.9 | +0.40% | 259 922 |
25/24/25 | 162.2 | -0.06% | 817,488 |
24/24/24 | 162.3 | -1.45% | 706,280 |
21/24/21 | 164.7 | +0.02% | 859,587 |
20/24/20 | 164.6 | -1.21% | 913,888 |
Delayed Quote Nasdaq, June 26, 2024 at 10:34 pm IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.31% | 3,352B | |
+16.40% | 91.95B | |
+13.86% | 85.41B | |
+40.48% | 54.69B | |
-19.57% | 49.57B | |
+35.78% | 47.8B | |
-28.16% | 43.59B | |
+85.75% | 42.61B | |
-1.68% | 27.83B |
- Stock Market
- Equities
- NICE Stock
- NICE Stock